Dec. 25, 2014 SIGN IN | REGISTER
Download CQ Roll Call's Definitive Guide to the 114th Congress | Sign Up for Roll Call Newsletters | Get the Latest on the Roll Call App

Industry an Effective Partner in Preparing for Biological Threats | Commentary

Investments in BARDA and the Project BioShield Special Reserve Fund are a modest, yet critical, insurance policy against deadly threats. In our constrained fiscal environment, it is vital that we not lose sight of the importance of preparing for the worst. We cannot afford otherwise.

Jim Greenwood is the president and CEO of the Biotechnology Industry Organization in Washington, DC and a former Republican congressman from Pennsylvania.

comments powered by Disqus




Want Roll Call on your doorstep?